- 21+ Therapeutic Areas (Comprehensive Cardiometabolic and Complex Condition Foundation)
- 2.5x Engagement Boost (Sustained Medication Adherence & Persistence)
Enterprise Companion App Powered by Welldoc Health AI
Extend therapy beyond the pill with Welldoc’s white-label, regulatory-grade solutions.
Tailored for adherence. Scalable across your portfolio.
Accelerate Launch. Elevate Adherence.
Drive Real-World Outcomes.
Months, not years
Rapidly launch a flexible, regulatory-grade foundation tailored to your drug portfolio.
Proven outcomes
Drive sustained adherence, capture high-fidelity RWE, and deliver value across health plans.
Extending Therapeutic Value Beyond the Pill with Proven Scale, Safety, and Science
Regulatory Rigor & Engagement at Scale
While consumer health-tech solutions focus on optics, Welldoc delivers a proven enterprise architecture backed by rigorous clinical data, high member engagement, and global regulatory standards.
When evaluating a digital health partner to extend your therapy beyond the pill, Life Sciences leaders require proven scale, safety, and engagement.
- 11 FDA 510(k) Clearances* (Global Compliance Foundation)
- 100+ Clinical Publications (Peer-Reviewed Outcomes & RWE)
- PDURS & PCCP Ready (Pre-Built for FDA Software Labeling Compliance)
- 60+ Patents (Proprietary IP & Clinical Innovation)
- SOC 2 Type II & DiME Seal Verified (Enterprise Security & Digital Medicine)
Solving Critical Commercial Challenges with Digital-First Companion App
Commercial Challenge
Therapy Abandonment
Issue: Patients drop off complex health regimens during initiation, titration, or early side-effect onset.
Solution: AI-Guided Adherence & Persistence
Embedded AI delivers real-time medication support, titration coaching, side-effect tracking, and habit-building nudges.
Fragmented Patient Solutions
Issue: Disjointed point solutions, portals, and generic apps frustrate patients with complex needs.
Solution: Personalized, Consumer-Centric Experience
A unified, AI-powered platform provides connected, seamless support across the entire patient journey.

Siloed Solutions by Therapeutic Area
Issue: Single-condition apps trap data, ignore comorbidities, and erode long-term patient trust.
Solution: Scalable, Multi-Condition Support
One clinically validated platform spans complex conditions, streamlining care and unlocking portfolio-wide insights.
Delayed Launch Timelines
Issue: Custom digital health solutions take years to build, incur significant cost, and are hard to scale or evolve.
Solution: Rapid Speed to Market
Launch an agile, white-labeled solution tailored to your therapeutic areas in a matter of months.
Proven Impact in Practice

Today’s healthcare consumers expect a seamless and connected experience focused on access, services, and real-time support. Welldoc helps you deliver it. Be at the epicenter of their journey by combining the power of your therapies with our AI-driven technology.
- Medication adherence support
- Seamless device and data connection
- Tailored educational content and coaching
- Integration with DTC services and partners
- Consistency across your brands and therapies
Best-in-Class Partner Capabilities
Welldoc checks all six requirements to de-risk partnership, launch, and scale while connecting use to measurable therapy performance.
When evaluating a digital health partner, Life Sciences leaders require proven scale, safety, and engagement. Here is how Welldoc meets and exceeds the industry standard.
Business model clarity
Configurable scope, pricing, SLAs, and ownership
Pharma operating experience
MLR, safely, governance, and launch execution
Evidence generation
Programs designed to connect use to outcomes
Regulatory Maturity
FDA-cleared heritage and quality discipline
Ecosystem integration
Patients, HCPs, devices, EHRs, and data
Adoption & scale
Reusable platform across assets and programs
What does Welldoc Health AI Mean for You and Your Patients?
We built the foundation and framework of our Welldoc platform with deep clinical rigor, leveraging the power of AI alongside enterprise-grade security and compliance.
By combining robust clinical logic with our proprietary cardiometabolic data, we deliver highly personalized, accurate guidance and recommendations for every patient, effectively helping to support closing the healthcare data loop gap that exists across care models today.

Expansive Condition Support Across Complex Patient Journeys
Welldoc’s comprehensive foundation has the flexibility and scale to support multiple therapeutic areas and complex comorbidities. Our Healthcare-Ready AI levels up personalized care with specific guidance, education, and support required to navigate complex clinical journeys.
AI-powered metabolic guidance, vital device connections, obesity management, medication management, and holistic weight journey support.
Dynamic symptom tracking, critical biomarker data integration, and complex injection regimen support.
Caregiver app connectivity, complex polypharmacy tracking, and sleep insight integration.
Complex medication management, infusion logging, toxicity tracking, and side-effect management.
Proven Impact in Practice

Frequently Asked Questions
Q: How fast can we deploy a custom digital companion app with Welldoc?
A: Turnkey, non-integrated deployments launch in a matter of days or weeks. Full white-label custom apps can deploy in a few months via our secure, multi-tenant SaMD architecture. For existing portals, modular features integrate seamlessly using secure SDKs, APIs, and SSO.
Q: Can Welldoc integrate with our existing enterprise systems, EHRs, and patient hubs?
A: Yes, Welldoc acts as the configurable patient engagement and connectivity layer that seamlessly surrounds and connects with your existing enterprise infrastructure. Rather than replacing your current hubs, CRMs, or portals, Welldoc connects via secure APIs and SSO into your broader operational and commercial ecosystem.
Q: How does Welldoc support FDA, PDURS and regulatory requirements for Life Sciences/BioPharma?
A: Welldoc is built on an enterprise regulatory foundation featuring 11 FDA 510(k) clearances, built-in readiness for Prescription Drug Use-Related Software (PDURS), SOC 2 Type II data security certification, and alignment with the DiME Seal for digital clinical rigor. Our pre-built architecture supports PCCP, HIPAA, CE Mark, and Health Canada standards to streamline global regulatory approval.
Q: How does a digital companion app improve long-term medication persistence beyond the pill?
A: Welldoc drives long-term medication persistence by closing the critical support gap between clinical visits with real-time, AI-driven daily guidance. SIMON, Welldoc's conversational AI assistant, provides titration tracking, side-effect logging, and habit-building nudges to close support gaps between doctor visits, delivering 2.5x higher engagement compared to traditional patient support programs.
Q: How does the Welldoc platform support multiple therapeutic areas?
A: Welldoc’s FDA-cleared platform has a strong foundation built across 21+ conditions, supporting patients across multiple dimensions of health, including medications, nutrition, exercise and symptoms. We collaborate directly with BioPharma partners to ensure the appropriate information to support specific therapies and complex conditions is available. The platform engages patients in their daily routines to foster better health habits, improve medication persistence, and drive measurable clinical outcomes.

Let’s build the next generation of healthcare-ready AI solutions together.
Leverage our regulatory-grade technology and clinical expertise to add lasting value to your commercial brands and patients. Contact our team today to schedule an executive brief and live platform demonstration.
.webp)
.avif)
*Welldoc® Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit welldoc.com/indications-for-use/. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.
** PMDA in process


